Neurones S.A. (EPA:NRO)
France flag France · Delayed Price · Currency is EUR
37.85
+0.55 (1.47%)
May 14, 2026, 5:35 PM CET

Neurones Cash Flow Statement

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
52.0752.5649.4144.2437.71
Depreciation & Amortization
19.5517.6615.915.4114.94
Loss (Gain) From Sale of Assets
0.24-0.09-0.35-0.64-0.02
Loss (Gain) From Sale of Investments
---0.82-0.030.09
Stock-Based Compensation
4.215.114.393.361.99
Other Operating Activities
-4.150.692.145.827.75
Change in Other Net Operating Assets
-0.648.461.39-13.192.05
Operating Cash Flow
71.2884.3872.0854.9764.5
Operating Cash Flow Growth
-15.53%17.08%31.12%-14.77%-4.15%
Capital Expenditures
-10.44-12.04-17.98-10.61-6.58
Sale of Property, Plant & Equipment
0.090.260.080.060.16
Cash Acquisitions
-11.63-7.98-4.61-2.62-5.08
Divestitures
1.551.532.172.311.49
Investment in Securities
-0.73-1.47-1.22-1.39-0.6
Investing Cash Flow
-21.16-19.69-21.57-12.26-10.62
Long-Term Debt Issued
2.495.116.390.070.02
Long-Term Debt Repaid
-13.73-12.44-9.98-7.14-6.62
Net Debt Issued (Repaid)
-11.23-7.33-3.59-7.07-6.61
Issuance of Common Stock
--0.06-0.09
Repurchase of Common Stock
-0.32-0.03--0.11-
Common Dividends Paid
-31.62-29.13-26.65-24.22-
Other Financing Activities
7.562.013.12-4.67-0.49
Financing Cash Flow
-35.62-34.48-27.06-36.08-55.43
Foreign Exchange Rate Adjustments
-0.280.360.030.250.13
Net Cash Flow
14.2330.5723.486.89-1.42
Free Cash Flow
60.8472.3554.0944.3657.92
Free Cash Flow Growth
-15.90%33.74%21.93%-23.40%-3.62%
Free Cash Flow Margin
7.10%8.93%7.30%6.67%9.99%
Free Cash Flow Per Share
2.502.972.231.832.39
Cash Interest Paid
0.890.910.460.890.22
Cash Income Tax Paid
27.8424.8125.3524.1316.16
Levered Free Cash Flow
55.5959.1152.6939.3454.94
Unlevered Free Cash Flow
56.6960.2553.5940.455.55
Change in Working Capital
-0.648.461.39-13.192.05
Source: S&P Global Market Intelligence. Standard template. Financial Sources.